FDA Approves First-of-its-Kind SenSight™ Directional Lead System for DBS Therapy – BioSpace

FDA Approves First-of-its-Kind SenSight™ Directional Lead System for DBS Therapy – BioSpace
Source: Google NewsPublished on 2021-06-07